Recurrent multiple myeloma
Clinical trials for Recurrent multiple myeloma explained in plain language.
Never miss a new study
Get alerted when new Recurrent multiple myeloma trials appear
Sign up with your email to follow new studies for Recurrent multiple myeloma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged immune cells take on Hard-to-Treat myeloma
Disease control CompletedThis early-phase study tests a new treatment for multiple myeloma that has returned or stopped responding to prior therapies. It combines specially engineered natural killer (NK) cells (called TiNK) with an antibody drug (isatuximab) and standard chemotherapy. The main goal is to…
Matched conditions: RECURRENT MULTIPLE MYELOMA
Phase 1 • Sponsor: Elvira Umyarova • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Lab tests could pick the right drug for tough myeloma cases
Knowledge-focused CompletedThis study tests a new way to choose treatments for people with multiple myeloma or plasma cell leukemia that has returned or stopped responding to standard therapy. Researchers use a lab test that checks many drugs at once, along with genetic information, to find which drug or d…
Matched conditions: RECURRENT MULTIPLE MYELOMA
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC